ProMIS Neurosciences Inc PMN

FDA extends review period for Aducanumab

[Fryinpan]

https://seekingalpha.com/news/3656103-biogen-rises-10-after-fda-extends-review-period-for-aducanumab-application

[retiredcop]

CAMBRIDGE, Mass. and TOKYO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period by three months for the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s disease. The updated Prescription Drug User Fee Act (PDUFA

[Mole101]

Interesting day in the markets, I wander if that news has something to do with PMN activity today ?... House  Bought  Sold  Net  House 001 Anonymous Bought $14,065 Volume 147,600

[M101]

Looks more like some PMN traders have known or suspected this for up to a week. Consultant's strategy backfires again!  

[retiredcop]

https://www.bloomberg.com/news/articles/2021-01-30/biogen-alzheimer-s-drug-puts-fda-s-judgment-in-harsh-spotlight

[M101]

I wonder if pp participants who weren't willing to buy at .12 will feel any different at .09 or .06 while our consultants continue to drain the coffers?  Could be worse though, they could have written their contracts in fixed rate bitcoin.